A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58

被引:95
作者
Héritier, C
Dubouix, A
Poirel, L
Marty, N
Nordmann, P
机构
[1] Univ Paris 11, Fac Med Paris Sud, Assistance Publ Hop Paris, Hop Bicetre,Serv Bacteriol Virol, F-94275 Le Kremlin Bicetre, France
[2] CHU Rangueil, Lab Bacteriol Hyg, F-31403 Toulouse 4, France
关键词
A; baumannii; carbapenem resistance; nosocomial infections;
D O I
10.1093/jac/dkh500
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: The aim of this study was to analyse the spread of the bla(OXA-58) gene as a source of carbapenem resistance in Acinetobacter baumannii in the burns unit of a university hospital in Toulouse in 2003-2004. Methods: Six carbapenem-resistant A. baumannii isolates from six patients, and a carbapenem-resistant environmental A. baumannii isolate were collected in the burns unit of the Rangueil hospital (Toulouse). Susceptibility tests were carried out by disc diffusion and agar dilution methods. The detection of the bla(OXA-58) gene was conducted by PCR followed by sequence analysis. Plasmids were extracted and hybridized with a probe specific for bla(OXA-58). DNA fingerprints were obtained by pulsed-field gel electrophoresis of ApaI- or SmaI-digested chromosomal DNA of the tested strains. Results: The multidrug-resistant clinical isolates had a similar 30 kb plasmid that encoded the carbapenem-hydrolysing beta-lactamase OXA-58. These isolates were clonally related. The unrelated environmental carbapenem-resistant A. baumannii isolate had a similar bla(OXA-58)-carrying plasmid, suggesting spread of this gene. Conclusions: A novel oxacillinase was the source of carbapenem resistance in the A. baumannii isolates. Its gene was plasmid-, but not integron-borne.
引用
收藏
页码:115 / 118
页数:4
相关论文
共 12 条
  • [1] Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii
    Afzal-Shah, M
    Woodford, N
    Livermore, DM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 583 - 588
  • [2] [Anonymous], 2003, NCCLS Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, V6th
  • [3] Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features
    BergogneBerezin, E
    Towner, KJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) : 148 - +
  • [4] OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain
    Bou, G
    Oliver, A
    Martínez-Beltran, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1556 - 1561
  • [5] Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil
    Dalla-Costa, LM
    Coelho, JM
    Souza, HAPHM
    Castro, MES
    Stier, CJN
    Bragagnolo, KL
    Rea-Neto, A
    Penteado, SR
    Livermore, DM
    Woodford, N
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) : 3403 - 3406
  • [6] Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii
    Héritier, C
    Poirel, L
    Aubert, D
    Nordmann, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 268 - 273
  • [8] Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain
    Lopez-Otsoa, F
    Gallego, L
    Towner, KJ
    Tysall, L
    Woodford, N
    Livermore, DM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (12) : 4741 - 4743
  • [9] Naas T, 1999, CURR PHARM DESIGN, V5, P865
  • [10] Poirel L., 2002, Current Pharmaceutical Biotechnology, V3, P117, DOI 10.2174/1389201023378427